本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Edgewise Therapeutics, Inc.

16.91
+0.23001.38%
盘后16.910.00000.00%16:40 EDT
成交量:142.87万
成交额:2,410.12万
市值:17.78亿
市盈率:-11.68
高:17.30
开:16.64
低:16.05
收:16.68
数据加载中...
2021/11/08

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/03

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/18

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/13

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/08/09

重要事件披露

8-K - Current report
2021/08/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/18

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/13

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/03

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/08

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/05

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/31

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/03/30

重要事件披露

8-K - Current report
2021/03/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/26

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/03/22

SEC问询函

CORRESP [Cover] - Correspondence
2021/03/22

SEC问询函

CORRESP [Cover] - Correspondence